A member of our partners BOPA has published a book - ‘Can community pharmacists support patients who take oral anticancer medication?’ By Melanie Dalby is now available via Amazon.

The book aims to promote the current and potential support that community pharmacists provide to patients who receive oral anticancer medication. This research started through a Darzi Fellowship (a bespoke leadership programme), which led onto several studies and publications guided by the Medical Research Council’s framework for developing and evaluation of complex interventions. This book details the work completed during the Darzi Fellowship and beyond.

Please share with any colleagues who may be interested. BOPA is the British Oncology Pharmacy Association, founded in the autumn of 1996 and grew out of the United Kingdom Clinical Pharmacy Association (UKCPA).

The purpose of BOPA, which is a registered charity, is to promote excellence in the pharmaceutical care of patients with cancer through education, communication, research and innovation by an alliance of hospital, community and academic pharmacists, pharmacy technicians, those in the pharmaceutical industry and other healthcare professionals.

BOPA’s principal objective is to promote excellence in the pharmaceutical care of patients with cancer, thereby improving their quality of life.

BOPA is proud to be partnered with the Oncology Convention, click here to learn more about BOPA, and here to register for the 2020 Oncology Convention!